Today, Tessera is proud to announce the appointment of new industry leaders who will help us pioneer the future of #GeneticMedicine to our Board of Directors. Welcome Elliott Sigal and Mary Rozenman Mary Rozenman! businesswire.com/news/home/2021…

Huge thank you to our process engineering and imaging ML colleagues at insitro for the fantastic automation update tour for the G&A leadership! Was great to confuse the lab team with Daphne Koller, myself, and the BD, finance, and legal colleagues in lab coats... 👩🏻‍🔬

Thank you to STAT and Erin Brodwin for this great feature on the addition of tech industry leader Tom Stocky to our team as VP Product! We’re thrilled to have Tom onboard as we scale our data product.

Thrilled to announce redun, our first open-sourced workflow at insitro built by Matt Rasmussen and team. We hope redun can be enabling to others working at the convergence of compute and multi-modal biologic data. If this is exciting - come join Daphne Koller and our team!

Great additional color on insitro open sourcing redun today from Matt Rasmussen

Great to share some of our exciting science at insitro. If this is up your alley, check us out - we are hiring for a number of roles across compute, cell biology, drug discovery, and G&A at insitro.com/careers. Join us!

Thrilled to welcome four amazing leaders to insitro — Jevan as CPO, Martha Rook as CTOO, Theofanis Karaletsos as VP DS/ML, Ellen as VP biomarker sciences. Want to work with them too? We’re hiring!

Great work by Matt Rasmussen and the software engineering team at insitro featured in a recent AWS blog. Check it out!

Thrilled with today’s news that Philip Tagari is joining insitro as CSO and can’t wait to work together!

Congratulations, Daphne Koller! An amazing honor and all of us at insitro are cheering for you! 🤩🙌🚀

It's go time! #inVivoWeek2023 officially started today at insitro with an incredible, inspiring fireside chat between trailblazing healthcare leader Dr. Sue Desmond-Hellmann and our Founder & CEO Daphne Koller. Brace yourself for a week of learning, collaboration & boundless #innovation!

insitro unveiled an inspiring new tradition to celebrate insitrocytes' commitment to our mission. Unique insitro anniversary blocks, awarded yearly, serve as symbols of our shared journey. Thank you to our world-class team working to transform #drugdiscovery. #ML #inVivoWeek2023

A glimpse into our work insitro with more to come! Huge congrats to the amazing group of insitrocytes on our journey to transform biology discovery for better medicines.

We're thrilled to launch a new insitro.com, an immersive portal into our platform, pipeline, science, technology & culture – the intersection of which makes us a company like no other! Check out our teaser video & bookmark us to follow our science, news & progress.

Excited and proud to launch the new insitro website in an attempt to break open the black box. Check it out and more to come!

Biotech founded by Daphne Koller makes stir on eve of JPM conference with new papers on drugs for cancer, ALS, liver disease; poaches new CMO from Pfizer. trib.al/lKUkjRB

Thrilled to continue to share more about our work and progress at insitro with a deep dive on our science heading into #JPM2024 ! Huge thanks to Matthew Herper and STAT for the profile! Come see more when Daphne Koller presents at the conference Monday 3:30pm !

We’re thrilled to welcome Dr. S. Michael Rothenberg as insitro’s CMO. With 2 decades of clinical care & drug development experience, his innovations in data-driven trial design will be critical as we advance our pipeline toward the clinic. businesswire.com/news/home/2024…

Our CSO Philip Tagari recently joined a16z Bio + Health's Vijay Pande for an exciting conversation on his multi-decade journey in drug discovery and the role #AI and data at scale are playing in moving from “hunting for” drugs to engineering safe and effective therapeutics.

Honored and thrilled to welcome AI/ML rockstar Emily Fox to insitro after decades across Stanford University Apple and University of Washington. See more in the release below with comments from Emily and Daphne Koller!